SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-005733
Filing Date
2021-05-04
Accepted
2021-05-04 16:55:56
Documents
72
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ptgx-20210331x10q.htm   iXBRL 10-Q 1592802
2 EX-31.1 ptgx-20210331xex31d1.htm EX-31.1 10119
3 EX-31.2 ptgx-20210331xex31d2.htm EX-31.2 9945
4 EX-32.1 ptgx-20210331xex32d1.htm EX-32.1 9486
5 GRAPHIC ptgx-20210331x10q007.jpg GRAPHIC 64954
  Complete submission text file 0001558370-21-005733.txt   7164182

Data Files

Seq Description Document Type Size
6 EX-101.SCH ptgx-20210331.xsd EX-101.SCH 56361
7 EX-101.CAL ptgx-20210331_cal.xml EX-101.CAL 48713
8 EX-101.DEF ptgx-20210331_def.xml EX-101.DEF 185083
9 EX-101.LAB ptgx-20210331_lab.xml EX-101.LAB 458724
10 EX-101.PRE ptgx-20210331_pre.xml EX-101.PRE 375041
11 EXTRACTED XBRL INSTANCE DOCUMENT ptgx-20210331x10q_htm.xml XML 1223486
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37852 | Film No.: 21889480
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences